Loading…

Cerebral Microvascular and Systemic Effects Following Intravenous Administration of the Perfluorocarbon Emulsion Perftoran

Oxygen-carrying perfluorocarbon (PFC) fluids have the potential to increase tissue oxygenation during hypoxic states and to reduce ischemic cell death. Regulatory approval of oxygen therapeutics was halted due to concerns over vasoconstrictive side effects. The goal of this study was to assess the p...

Full description

Saved in:
Bibliographic Details
Published in:Journal of functional biomaterials 2016-11, Vol.7 (4), p.29-29
Main Authors: Abutarboush, Rania, Saha, Biswajit K, Mullah, Saad H, Arnaud, Francoise G, Haque, Ashraful, Aligbe, Chioma, Pappas, Georgina, Auker, Charles R, McCarron, Richard M, Moon-Massat, Paula F, Scultetus, Anke H
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Oxygen-carrying perfluorocarbon (PFC) fluids have the potential to increase tissue oxygenation during hypoxic states and to reduce ischemic cell death. Regulatory approval of oxygen therapeutics was halted due to concerns over vasoconstrictive side effects. The goal of this study was to assess the potential vasoactive properties of Perftoran by measuring brain pial arteriolar diameters in a healthy rat model. Perftoran, crystalloid (saline) or colloid (Hextend) solutions were administered as four sequential 30 min intravenous (IV) infusions, thus allowing an evaluation of cumulative dose-dependent effects. There were no overall changes in diameters of small-sized (
ISSN:2079-4983
2079-4983
DOI:10.3390/jfb7040029